lang: en_US

Press Release: Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology

•    Acquisition allows Noventure to maintain focus on medical devices and grow therapeutic areas in which it operates 
•    Medical devices contain Olea Europaea leaf extract, showing healing properties  for ulcers and skin wounds
•    Innovative products are CE marked and available for licensing worldwide

Barcelona, Spain, April 19, 2021 – Noventure, specialized in licensing innovative substance-based medical devices and specialist food supplements, today announces it has acquired the Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology. 

Read more
Press Release: Noventure signs exclusive license agreement for innovative food supplement EPA3G

•    EPA3G a unique, patented emulsion of high purity EPA, in drinkable single sachet - containing daily dose of 3g
•    Deal gives Noventure licensing rights in over 50 countries
•    Agreement signed with global partner Azur Global Nutrition

Barcelona, Spain, February 17th, 2021 - Noventure announces today that it has signed an exclusivity agreement for the licensing of the innovative food supplement EPA3G, with global partner Azur – a division of Solutex (Madrid, Spain).

Read more
First launch of UTIPRO® PLUS AF in EUROPE

We are pleased to announce the launch of UTIPRO® PLUS AF in Portugal.
Portugal is the first European country in which UTIPRO® PLUS AF has been launched in its composition free from ingredients of animal origin. The product is distributed by Sangool, a Portuguese company specialized in the detailing and the distribution of high quality and innovative products, mainly addressed to women health and care.

Read more